Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
6-Mercaptopurine riboside (6-MPR) is a derivative of the inhibitor of purine synthesis and interconversion 6-mercaptopurine (Item No. 23675).1 It is active against S. faecalis when used at concentrations ranging from 0.05 to 15 mg/ml.2 6-MPR (0.5, 1, or 1.5 mM) inhibits autophagy and cholesterol synthesis in isolated and washed rat hepatocytes, an effect that can be prevented by the adenosine kinase inhibitor 5-iodotubercidin (Item No. 10010375).3 In vivo, 6-MPR (17, 35, or 70 mg/kg per day) decreases tumor growth in mice bearing 6-mercaptopurine susceptible, but not 6-mercaptopurine-resistant, adenocarcinoma 755 tumors.2
WARNING This product is not for human or veterinary use.
1. Design of analogs of purine nucleosides with specifically altered activities as substrates for nucleoside-
2. Anticancer activity of purine antagonists and their ribosides. I. Comparative studies with 6-
3. Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-